The global Real Time Polymerase Chain Reaction (qPCR) Market reached a valuation of USD 4.64 Billion in 2021 and is projected to experience a compound annual growth rate (CAGR) of 7.8% over the forecast period. This growth is primarily attributed to the rising prevalence of chronic illnesses such as HIV, malaria, hepatitis, and cancer, coupled with substantial advancements in qPCR technology, resulting in improved device performance and efficiency.
In 2020, the World Health Organization (WHO) reported nearly 10 million deaths globally, with approximately 30% of cancer cases in low- and lower-middle-income countries being attributed to cancer-causing agents like Human Papillomavirus (HPV) and hepatitis. Cancer remains a leading cause of mortality worldwide, with breast cancer being the most common type, with an estimated 290,560 new cases anticipated in the United States in 2022.
Real-time Polymerase Chain Reaction (qPCR), also known as quantitative polymerase chain reaction, is a molecular biology laboratory technique based on Polymerase Chain Reaction (PCR) that enables the monitoring of PCR reactions in real-time.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/5500
Competitive Landscape:
The competitive landscape of the global Real Time Polymerase Chain Reaction (qPCR) market is moderately consolidated with a few major companies operating on global and regional levels. Major companies are engaged in product development and strategic alliances to expand their respective product portfolios and gain a robust footprint in the global market.
Some major companies in the market report include Abbott, Bio-Rad Laboratories Inc., Thermo FIsher Scientific, F. Hoffman-La Roche Ltd, BD, Agilent Technologies, Integrated DNA Technologies Inc., Standard BioTools, Takara Bio Inc., and Lumex Instruments.
To know more about the report @https://www.reportsanddata.com/report-detail/real-time-polymerase-chain-reaction-qpcr-market
The Real Time Polymerase Chain Reaction (qPCR) market is influenced by several driving factors and constraints:
Driving Factors:
- Increasing Prevalence of Chronic Diseases: The growing incidence of chronic diseases such as HIV, cancer, hepatitis, and others is a significant driver for the qPCR market. qPCR is instrumental in diagnosing and monitoring these diseases.
- Technological Advancements: Continuous advancements in qPCR technology have led to more efficient and high-performance devices, which attract healthcare professionals and researchers seeking accurate and rapid results.
- Demand for Molecular Diagnostics: Molecular diagnostics, including qPCR, are becoming increasingly crucial in personalized medicine, where treatment is tailored to an individual's genetic makeup. This demand is fueling market growth.
- Research and Development Initiatives: Investments in research and development to expand the applications of qPCR in genomics, proteomics, and drug discovery are stimulating market growth.
Restraints:
- High Costs: qPCR equipment and reagents can be expensive, limiting their adoption in resource-constrained settings and smaller laboratories.
- Complexity: qPCR techniques require skilled personnel and can be complex to perform, which may restrict their use in certain healthcare settings.
- Competition from Alternative Technologies: Alternative molecular diagnostic technologies, such as next-generation sequencing (NGS), may compete with qPCR in certain applications, potentially impacting market growth.
- Regulatory Challenges: Stringent regulatory requirements and approval processes for qPCR devices can slow down their introduction to the market and increase development costs.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/5500
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370a
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
